ReviewJournal of the Korean Society of Radiology2026
MRI for Diagnosing Musculoskeletal Tumors: A Qualitative and Quantitative Analysis of Tissue Composition.
Review in Journal of the Korean Society of Radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Musculoskeletal (MSK) tumors are neoplasms that arise in the bones, cartilage, muscles, tendons, nerves, and synovium. These lesions are highly diverse, comprising various tissue components such as mature fat, fluid, hematoma, and fibrous tissue. MRI is a crucial modality for diagnosing MSK tumors, providing both qualitative and quantitative assessments of tissue composition. The key tissue components of MSK tumors that are identifiable on MRI include mature fat and fluid. However, hyperintense mimickers-such as subacute hematomas on T1-weighted image (T1WI) and pseudocystic lesions on T2-weighted image (T2WI)-can complicate MRI interpretation. Masses with non-specific MRI features-such as intermediate signal intensity (SI) on T1WI and high SI on T2WI-require differential diagnosis. Special attention should be paid to the tumor's specific location, imaging signs, patterns of low-SI foci on both sequences, and features suggestive of malignancy, with biopsy indicated in uncertain cases. Advanced MRI techniques enhance diagnostic precision. DIXON quantifies fat content, diffusion-weighted imaging assesses cellularity with tumor heterogeneity, and dynamic contrast-enhanced MRI quantifies perfusion. Ultimately, integrating conventional and functional MRI analyses is essential to accurately characterize the diverse and complex nature of MSK tumors.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.